Navigation Links
Legislation Would Deny Floridians Access to Needed Medicines from Their Trusted Independent Community Pharmacies, and Instead Favor Publicly Traded Chain Pharmacies
Date:3/31/2011

ALEXANDRIA, Va., March 31, 2011 /PRNewswire-USNewswire/ -- National Community Pharmacists Association Executive Vice President and CEO Kathleen Jaeger issued the following statement today in response to the Florida House Judicial Committee's passage of HB 7095, legislation sponsored by State Rep. Rob Schenck, and in particular an amendment that would restrict the dispensing of controlled substances on Schedule II and Schedule III to publicly traded pharmacy chains or only those independent community pharmacies that have been in business more than 10 years:

(Logo: http://photos.prnewswire.com/prnh/20100106/DC33253LOGO)

"We all support efforts to keep illegal substances out of the hands of those who are addicted to drugs. However, as good as Representative Schenck's intentions may be, this legislation would result in keeping medicines from actual patients who need them.  In essence, it would make real patients and independent community pharmacies collateral damage between the War on Drugs and the War on Pain.

"This bill is misguided, and does a great disservice to patients under the guise of drug diversion. There is no credible evidence to suggest that drug diversion occurs at a higher level in independent community pharmacies than that of chains. Creating an uneven competitive playing field does nothing to advance the resolution of the underlying drug diversion issue, and forces many patients to leave their trusted independent community pharmacist to obtain their prescriptions at chain pharmacies. This is particularly a problem in underserved rural and urban communities, where independent pharmacists may be the only health care provider available. Under this bill, these patients with legitimate health needs will be denied timely access to essential medications.

"In addition, with Florida's unemployment rate at 11.5 percent and state leaders grappling with crippling revenue shortfalls, it would be incredibly short-sighted for the legislature to put its thumb on the scales against local, family owned pharmacies. Florida's 1,303 independent community pharmacies are pillars of their communities, employing 13,942 Floridians and indirectly supporting many more jobs. This legislation would undermine those jobs at the worst possible time by sending Florida dollars out of state via the nearest Big Box chain pharmacy.

"On behalf of patients with real health needs, independent community pharmacists will work vigorously to defeat this misguided proposal. In the meantime, we look forward to working cooperatively with state leaders on reasonable solutions to combat the abuse of controlled substances."

The National Community Pharmacists Association (NCPA®) represents the interests of America's community pharmacists, including the owners of more than 23,000 independent community pharmacies, pharmacy franchises, and chains. Together they represent a $93 billion health-care marketplace, have more than 315,000 employees including 62,400 pharmacists, and dispense over 41% of all retail prescriptions. To learn more go to www.ncpanet.org or read NCPA's blog, The Dose, at http://ncpanet.wordpress.com.


'/>"/>
SOURCE National Community Pharmacists Association
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. California Legislature Passes Historic HIV Testing Bill (AB 682); AHF Urges Governor to Sign Crucial Lifesaving Legislation
2. New Legislation Seeks to Boost Participation in Clinical Trials for Rare Diseases
3. Control Risks Forecasts New Reality for Business in 2011 Brought by Emerging Markets, Legislation
4. Bi-Partisan Legislation Introduced Would Repeal Controversial Medicare Competitive Bidding Requirements for Home Medical Equipment
5. Organ Donor Shortage Remains Obstacle for Would-Be Transplant Patients Despite Better Medicine
6. A Drug With Efficacy Superior to That of Xenical at Inducing Weight Loss Would Earn a 40 Percent Patient Share in the Obesity Drug Market
7. A First-Line Therapy for Renal Cell Carcinoma that can Increase Overall Survival when Compared with Sutent Would Earn a Higher Patient Share in the United States Than in Europe
8. New Federal Stem Cell Rules Would Hinder Existing Research, Consumer Group Warns
9. For Breast Cancer Treatment, an Agent That Can Achieve an Overall Survival Benefit Would Pose the Greatest Challenge to Avastins Dominance in Europe
10. An Acute Migraine Therapy That is Not Contraindicated in Patients With a History of Vascular Disease Would Earn a 45 Percent Patient Share in the United States, According to Surveyed Neurologists
11. Three in Ten Americans Would Use Their Cell Phone to Track Personal Health, Finds PricewaterhouseCoopers
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/20/2017)... , April 20, 2017  Cogentix Medical, ... focused on providing the Urology, Uro/Gyn and Gynecology ... that Ash Keswani has joined the Company as ... this newly created position, Mr. Keswani will report ... CEO. "Our organization is delighted that ...
(Date:4/20/2017)... -- Research and Markets has announced the addition of ... Expanding Injectables Market and Increasing Usage of Complex Biologics during the ... ... from USD 20 Billion in 2015 to around USD 26 Billion ... Innovation Driven by Rapidly Expanding Injectables Market and Increasing Usage of ...
(Date:4/20/2017)... Eyevensys, a private biotechnology company ... expression technology that enables the safe, local, sustained production ... wide range of ophthalmic diseases, announces it has received ... Agency (MHRA) to advance its technology into clinical development. ... The EyeCET ...
Breaking Medicine Technology:
(Date:4/24/2017)... , ... April 24, 2017 , ... My T Chai, ... its products are now available for purchase on RevNutrition.com, a popular website specializing in ... first produced and popularized in ancient India and Siam. It spread across Asia and ...
(Date:4/24/2017)... ... April 24, 2017 , ... symplrTM, a leading ... today announced that Kyle Allain has joined the company as Vice President and ... operations, including provider, payor and managed care solutions. , A seasoned executive ...
(Date:4/24/2017)... ... 24, 2017 , ... In 2017, up to 78,000 new ... of them will be malignant.(1) As research into precision medicine continues, both patients ... in the diagnosis and treatment of brain tumors. Healthcare facilities that are already ...
(Date:4/24/2017)... ... 2017 , ... Rod Burkett, CEO of Gardant Management Solutions, was recently featured ... at the forefront of Gardant since it was founded in 1999. His drive and ... of more than 40 new senior living communities. With his leadership, Gardant has grown ...
(Date:4/24/2017)... ... ... As a former supermodel known for her timeless beauty, Joan Severance knows ... is that she put all the words in her new book, "Manifest Your Mate: ... and sparkling sense of humor have inspired her to write a book on how ...
Breaking Medicine News(10 mins):